{"id":"https://openalex.org/W7213539424","doi":"https://doi.org/10.1007/s40121-026-01438-w","title":"Bivalent RSVpreF Effectiveness Against Respiratory Syncytial Virus (RSV)-Related Respiratory Disease Hospitalization and Emergency Department Visits Across Three RSV Seasons","display_name":"Bivalent RSVpreF Effectiveness Against Respiratory Syncytial Virus (RSV)-Related Respiratory Disease Hospitalization and Emergency Department Visits Across Three RSV Seasons","publication_year":2026,"publication_date":"2026-09-18","ids":{"openalex":"https://openalex.org/W7213539424","doi":"https://doi.org/10.1007/s40121-026-01438-w","pmid":"https://pubmed.ncbi.nlm.nih.gov/42758281","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13658733"},"language":"en","primary_location":{"id":"doi:10.1007/s40121-026-01438-w","doi":"https://doi.org/10.1007/s40121-026-01438-w","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-026-01438-w","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40121-026-01438-w.pdf","source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s40121-026-01438-w.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032804979","display_name":"Sara Yee Tartof","orcid":"https://orcid.org/0000-0003-2336-8476","observed_orcids":["https://orcid.org/0000-0003-2336-8476"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sara Y. Tartof","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA. Sara.Y.Tartof@kp.org"],"raw_orcid":"https://orcid.org/0000-0003-2336-8476","affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA. Sara.Y.Tartof@kp.org","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010659587","display_name":"Evan J Zasowski","orcid":"https://orcid.org/0000-0002-2595-1860","observed_orcids":["https://orcid.org/0000-0002-2595-1860"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan J. Zasowski","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046341888","display_name":"Negar Aliabadi","orcid":"https://orcid.org/0000-0002-9264-5089","observed_orcids":["https://orcid.org/0000-0002-9264-5089"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Negar Aliabadi","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122784643","display_name":"Gabriella Goodwin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriella Goodwin","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062829555","display_name":"Jeff M. Slezak","orcid":"https://orcid.org/0000-0002-6108-9198","observed_orcids":["https://orcid.org/0000-0002-6108-9198"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff Slezak","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031960337","display_name":"Vennis X. Hong","orcid":"https://orcid.org/0000-0002-6060-8419","observed_orcids":["https://orcid.org/0000-0002-6060-8419"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vennis Hong","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030619787","display_name":"Timothy B. Frankland","orcid":"https://orcid.org/0000-0002-0987-8405","observed_orcids":["https://orcid.org/0000-0002-0987-8405"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy B. Frankland","raw_affiliation_strings":["Kaiser Permanente Hawaii Center for Integrated Health Care Research, Honolulu, HI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente Hawaii Center for Integrated Health Care Research, Honolulu, HI, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5129008615","display_name":"Bradley Ackerson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley Ackerson","raw_affiliation_strings":["Southern California Permanente Medical Group, Harbor City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southern California Permanente Medical Group, Harbor City, CA, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100345244","display_name":"Qing Liu","orcid":"https://orcid.org/0000-0003-2028-973X","observed_orcids":["https://orcid.org/0000-0003-2028-973X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qing Liu","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158541745","display_name":"Sally Shaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sally Shaw","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003633408","display_name":"Sabrina Welsh","orcid":"https://orcid.org/0009-0000-7690-0062","observed_orcids":["https://orcid.org/0009-0000-7690-0062"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabrina Welsh","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057156734","display_name":"Banshri Kapadia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Banshri Kapadia","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049690667","display_name":"Brigitte C. Spence","orcid":"https://orcid.org/0000-0003-2386-9967","observed_orcids":["https://orcid.org/0000-0003-2386-9967"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brigitte C. Spence","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071474969","display_name":"Gregg S Davis","orcid":"https://orcid.org/0009-0008-0709-5838","observed_orcids":["https://orcid.org/0009-0008-0709-5838"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregg S. Davis","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015228397","display_name":"Joseph A. Lewnard","orcid":"https://orcid.org/0000-0002-8505-8839","observed_orcids":["https://orcid.org/0000-0002-8505-8839","https://orcid.org/0000-0002-5417-8475"]},"institutions":[{"id":"https://openalex.org/I95457486","display_name":"University of California, Berkeley","ror":"https://ror.org/01an7q238","country_code":"US","type":"education","lineage":["https://openalex.org/I95457486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph A. Lewnard","raw_affiliation_strings":["Division of Epidemiology and Division of Infectious Diseases and Vaccinology, School of Public Health, and Center for Computational Biology, College of Engineering, University of California, Berkeley, Berkeley, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Epidemiology and Division of Infectious Diseases and Vaccinology, School of Public Health, and Center for Computational Biology, College of Engineering, University of California, Berkeley, Berkeley, CA, USA","institution_ids":["https://openalex.org/I95457486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032812399","display_name":"Hina Chowdhry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hina Chowdhry","raw_affiliation_strings":["Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd Floor, Pasadena, CA, 91101, USA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021268492","display_name":"Michael P. Dutro","orcid":"https://orcid.org/0009-0005-7634-2183","observed_orcids":["https://orcid.org/0009-0005-7634-2183"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Dutro","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052814249","display_name":"Erica Leigh Chilson","orcid":"https://orcid.org/0000-0002-4417-3398","observed_orcids":["https://orcid.org/0000-0002-4417-3398"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erica Chilson","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076165148","display_name":"Alejandro D. Cane","orcid":"https://orcid.org/0000-0003-0778-6862","observed_orcids":["https://orcid.org/0000-0003-0778-6862"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro Cane","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070996687","display_name":"Kyla Hayford","orcid":"https://orcid.org/0000-0002-9872-2313","observed_orcids":["https://orcid.org/0000-0002-9872-2313"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyla Hayford","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077259705","display_name":"Elizabeth M. Begier","orcid":"https://orcid.org/0000-0002-1287-5416","observed_orcids":["https://orcid.org/0000-0002-1287-5416"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Begier","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5032804979"],"corresponding_institution_ids":["https://openalex.org/I1343052199"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.64258357,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"11","first_page":"3181","last_page":"3190"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abrysvo","display_name":"Abrysvo","score":0.8510000109672546},{"id":"https://openalex.org/keywords/respiratory-syncytial-virus","display_name":"respiratory syncytial virus","score":0.9610000252723694},{"id":"https://openalex.org/keywords/vaccine-effectiveness","display_name":"vaccine effectiveness","score":0.9559999704360962},{"id":"https://openalex.org/keywords/lower-respiratory-tract-disease","display_name":"lower respiratory tract disease","score":0.8059999942779541},{"id":"https://openalex.org/keywords/rsv-related-hospitalization","display_name":"RSV-related hospitalization","score":0.8240000009536743},{"id":"https://openalex.org/keywords/emergency-department-visits","display_name":"emergency department visits","score":0.9980000257492065},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.9089999794960022},{"id":"https://openalex.org/keywords/long-term-vaccine-protection","display_name":"long-term vaccine protection","score":0.7210000157356262},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.7570000290870667},{"id":"https://openalex.org/keywords/test-negative-case-control-study","display_name":"test-negative case-control","score":0.6259999871253967},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.7269999980926514},{"id":"https://openalex.org/keywords/kaiser-permanente-southern-california","display_name":"Kaiser Permanente Southern California","score":0.7120000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.909500002861023},{"id":"https://openalex.org/C2780724011","wikidata":"https://www.wikidata.org/wiki/Q1295316","display_name":"Emergency department","level":2,"score":0.7886000275611877},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.5812000036239624},{"id":"https://openalex.org/C2776620830","wikidata":"https://www.wikidata.org/wiki/Q4919211","display_name":"Bivalent (engine)","level":3,"score":0.5364000201225281},{"id":"https://openalex.org/C2776012195","wikidata":"https://www.wikidata.org/wiki/Q754447","display_name":"Respiratory tract infections","level":3,"score":0.5260000228881836},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.5011000037193298},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.4812999963760376},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4729999899864197},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.45419999957084656},{"id":"https://openalex.org/C2776399701","wikidata":"https://www.wikidata.org/wiki/Q3631290","display_name":"Lower respiratory tract infection","level":4,"score":0.43619999289512634},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.40959998965263367},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4090000092983246},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3862000107765198},{"id":"https://openalex.org/C2994330797","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory illness","level":3,"score":0.38199999928474426},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.37869998812675476},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.36910000443458557},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.36719998717308044},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3244999945163727},{"id":"https://openalex.org/C2993183539","wikidata":"https://www.wikidata.org/wiki/Q754447","display_name":"Respiratory infection","level":3,"score":0.3212999999523163},{"id":"https://openalex.org/C2779954635","wikidata":"https://www.wikidata.org/wiki/Q3508755","display_name":"Influenza-like illness","level":3,"score":0.31369999051094055},{"id":"https://openalex.org/C2779278377","wikidata":"https://www.wikidata.org/wiki/Q1351647","display_name":"Rhinovirus","level":3,"score":0.30709999799728394},{"id":"https://openalex.org/C143095724","wikidata":"https://www.wikidata.org/wiki/Q515895","display_name":"Odds","level":3,"score":0.30399999022483826},{"id":"https://openalex.org/C2780689484","wikidata":"https://www.wikidata.org/wiki/Q383260","display_name":"Influenza vaccine","level":3,"score":0.2833999991416931},{"id":"https://openalex.org/C61470247","wikidata":"https://www.wikidata.org/wiki/Q7229825","display_name":"Population study","level":3,"score":0.2630000114440918},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.259799987077713}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1007/s40121-026-01438-w","doi":"https://doi.org/10.1007/s40121-026-01438-w","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-026-01438-w","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40121-026-01438-w.pdf","source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},{"id":"doi:10.64898/2026.07.08.26357564","doi":"https://doi.org/10.64898/2026.07.08.26357564","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.07.08.26357564","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/07/13/2026.07.08.26357564.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},{"id":"pmid:42758281","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42758281","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious diseases and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13658733","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13658733/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infect Dis Ther","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:981c12dc42e9414d8cbbffa1cbbe330e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/981c12dc42e9414d8cbbffa1cbbe330e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Infectious Diseases and Therapy, Vol 15, Iss 11, Pp 3181-3190 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s40121-026-01438-w","doi":"https://doi.org/10.1007/s40121-026-01438-w","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-026-01438-w","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40121-026-01438-w.pdf","source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7213539424.pdf","grobid_xml":"https://content.openalex.org/works/W7213539424.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W4220727497","https://openalex.org/W4283027518","https://openalex.org/W4318262687","https://openalex.org/W4328047971","https://openalex.org/W4384926015","https://openalex.org/W4388947547","https://openalex.org/W4403506189","https://openalex.org/W4405365707","https://openalex.org/W4409430597","https://openalex.org/W4413846311","https://openalex.org/W4413852540","https://openalex.org/W4415380384","https://openalex.org/W4416586868","https://openalex.org/W7162509605"],"related_works":["https://openalex.org/W7168132965","https://openalex.org/W4416704293","https://openalex.org/W7162509605","https://openalex.org/W4406946263","https://openalex.org/W7204662647","https://openalex.org/W7168037155","https://openalex.org/W4415380384","https://openalex.org/W7116880254","https://openalex.org/W7204641926","https://openalex.org/W4413852540"],"abstract_inverted_index":{"ABSTRACT":[0],"Introduction":[1],"RSV":[2,22,33,86,247,265,285,290,396],"vaccines":[3,266],"reduce":[4,267],"the":[5,38,156,185,197,268,295,348,363],"risk":[6,269],"of":[7,237,243,270,388,394],"severe":[8,271],"outcomes":[9,226,272,377],"such":[10,273],"as":[11,274],"hospitalization":[12,275],"and":[13,102,151,159,180,188,207,253,276,343,351,357,402],"emergency":[14,277],"department":[15,278],"(ED)":[16,279],"visits":[17,57,143,280,317,335],"for":[18,97,104,227,281,378],"at":[19,77,228,282,379],"least":[20,229,283,380],"2":[21,284],"seasons":[23,60,87,200,231,286,320,382],"following":[24],"vaccination.":[25,42,62,322],"No":[26],"data":[27],"have":[28],"been":[29],"published":[30],"on":[31],"real-world":[32],"vaccine":[34,291],"effectiveness":[35,292],"(VE)":[36,293],"beyond":[37,294],"second":[39,296],"season":[40,161,190,297,353],"after":[41,61,162,191,232,287,298,321,354,383],"This":[43,64,245,303],"study":[44,304],"evaluates":[45,68,305],"bivalent":[46,69,112,306],"RSVpreF":[47,70,113,220,307,371],"VE":[48,71,121,138,169,195,308,330],"against":[49,139,170,223,309,331,374],"RSV-related":[50,140,171,224,310,332,375],"lower":[51,311],"respiratory":[52,312],"tract":[53,313],"disease":[54,108,314],"(LRTD)":[55,315],"hospitalizations/ED":[56,316],"throughout":[58,318],"3":[59,85,198,319,364],"Methods":[63],"retrospective":[65],"test-negative":[66],"case-control":[67],"among":[72,212],"adults":[73,239,390],"aged":[74],"\u226560":[75],"years":[76],"Kaiser":[78],"Permanente":[79],"Southern":[80],"California":[81],"with":[82,240,391],"LRTD":[83,141,172,225,333,376],"over":[84],"(11/24/2023\u20134/18/2026).":[88],"Cases":[89],"were":[90,95],"RSV-positive":[91],"without":[92],"coinfection.":[93],"Controls":[94],"negative":[96],"RSV,":[98],"hMPV,":[99],"influenza,":[100],"SARS-CoV-2,":[101],"positive":[103],"a":[105,241,392],"non-vaccine":[106],"preventable":[107],"pathogen.":[109],"Exposure":[110],"was":[111,122,144,173,201,324,336],"(Abrysvo)":[114],"receipt":[115],"\u226521":[116],"days":[117],"before":[118],"LRTD.":[119],"Adjusted":[120,194],"estimated":[123],"using":[124],"odds":[125],"ratios":[126],"from":[127,326],"multivariable":[128],"logistic":[129],"regression":[130],"or":[131],"generalized":[132],"estimating":[133],"equations.":[134],"Results":[135],"Overall,":[136,329],"adjusted":[137,168],"hospitalization/ED":[142,334],"80%":[145,208,337],"(95%":[146,149,153,175,178,182,203,209,338,341,345,359],"CI:68\u201387),":[147,339],"70%":[148,340],"CI:53\u201381),":[150,342],"51%":[152,344],"CI:-12\u201378)":[154,346],"in":[155,184,234,250,347,385,399],"first,":[157,186,349],"second,":[158,187,350],"third":[160,189,352],"vaccination,":[163,192,355],"respectively.":[164,193],"Among":[165],"non-immunocompromised":[166,213],"individuals,":[167],"87%":[174],"CI:75\u201394),":[176],"76%":[177],"CI:55\u201387),":[179],"58%":[181],"CI:-21\u201386)":[183],"across":[196,362],"combined":[199,365],"73%":[202,358],"CI:":[204,210,360],"64-80)":[205,361],"overall":[206],"69-87)":[211],"individuals.":[214],"Conclusion":[215],"These":[216,367],"results":[217,249,368,398],"suggest":[218,369],"Bivalent":[219,370],"provides":[221,372],"protection":[222,373],"three":[230,381],"vaccination":[233,248,288,299,384,397],"this":[235,263,327,386],"population":[236,387],"older":[238,389],"prevalence":[242,393],"comorbidities.":[244,395],"suggests":[246],"substantial":[251,400],"individual":[252,401],"public":[254,403],"health":[255,404],"benefit.":[256,405],"Key":[257],"Summary":[258],"Points":[259],"Why":[260],"carry":[261],"out":[262],"study?":[264,328],"Real-world":[289],"is":[300],"currently":[301],"unknown":[302],"What":[323],"learned":[325],"respectively,":[356],"seasons.":[366]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-09-18T00:00:00"}